MONETA GROUP INVESTMENT ADVISORS LLC
Position in CADL — Candel Therapeutics, Inc.
CIK 1120927
ST LOUIS, MO
Position in CADL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$205,148
-$35,073 QoQ
Shares Held
41,867
-1.5% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $1,862,709 across 8 Biotechnology names. CADL ranks #5 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
996 | $444,753 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
1,307 | $388,139 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
478 | $369,321 | |
| 4 | CAPR |
Capricor Therapeutics, Inc.
|
9,399 | $285,729 | |
| 5 | CADL |
Candel Therapeutics, Inc.
This page
|
41,867 | $205,148 | |
| 6 | ABUS |
Arbutus Biopharma Corp
|
26,000 | $117,000 | |
| 7 | ALXO |
Alx Oncology Holdings Inc
|
15,196 | $30,467 | |
| 8 | LGVN |
Longeveron Inc.
|
21,300 | $22,152 |
All Filings in CADL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $205,148 | 41,867 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $240,221 | 42,517 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $206,636 | 40,517 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $205,016 | 40,517 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $219,609 | 38,869 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||